Viatris VTRS
NASDAQ VTRS
$16.50 -0.11 (-0.66%)
As of: Sep 9, 2026 · 3:59 PM EDT

Viatris (VTRS) Other Non-Current Liabilities (2019 - 2026)

Viatris (VTRS) posted Other Non-Current Liabilities of $2.0 billion for Q2 2026, down 2.85% on a QoQ basis from $2.1 billion in Q1 2026, and up 10.24% year-over-year from $1.8 billion in Q2 2025.

Analysis

Viatris (VTRS) Other Non-Current Liabilities (2019 - 2026) Analysis & Trends

Viatris has reported Other Non-Current Liabilities for 8 years, with the latest figure at $2.0 billion in Q2 2026.

  • On a quarterly basis, Other Non-Current Liabilities rose 10.24% year-over-year to $2.0 billion in Q2 2026; TTM through Jun 2026 was $2.0 billion, a 10.24% increase from a year earlier, with the FY2025 full-year figure at $2.0 billion, up 3.9% from the prior year.
  • Other Non-Current Liabilities was $2.0 billion for Q2 2026 at Viatris, down from $2.1 billion in the prior quarter.
  • The five-year high for Other Non-Current Liabilities was $2.1 billion in Q1 2026, with the low at $1.5 billion in Q4 2023.
  • Average Other Non-Current Liabilities over 5 years is $1.8 billion, with a median of $1.8 billion recorded in 2024.
  • The sharpest annual moves came in 2022 and 2024: Other Non-Current Liabilities decreased 23.7% in 2022, then advanced 27.84% in 2024.
  • Over 5 years, Other Non-Current Liabilities stood at $1.8 billion in 2022, then fell by 13.64% to $1.5 billion in 2023, then increased by 27.84% to $1.9 billion in 2024, then rose by 3.9% to $2.0 billion in 2025, then grew by 0.41% to $2.0 billion in 2026.
  • The last three Other Non-Current Liabilities figures came in at $2.0 billion (Q2 2026), $2.1 billion (Q1 2026), and $2.0 billion (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 42.84 Bn 39.19 Bn 2.15 Bn
2 Viatris 19.13 Bn 18.24 Bn 1.46 Bn
3 Dr Reddys Laboratories 9.91 Bn 9.74 Bn 396.53 Mn
4 Amneal Pharmaceuticals 5.51 Bn 5.38 Bn 334.51 Mn
5 Bausch Health Companies 2.30 Bn 464.50 Mn 2.10 Bn
6 Alvotech 1.50 Bn 1.36 Bn 2.56 Mn
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn
8 Amphastar Pharmaceuticals 1.00 Bn 714.13 Mn 93.47 Mn
9 Fennec Pharmaceuticals 402.10 Mn 360.85 Mn 17.15 Mn
10 RedHill Biopharma 178.35 Mn 178.35 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.02 Bn
Mar 31, 2026 2.08 Bn
Dec 31, 2025 2.01 Bn
Sep 30, 2025 1.82 Bn
Jun 30, 2025 1.84 Bn
Mar 31, 2025 1.84 Bn
Dec 31, 2024 1.94 Bn
Sep 30, 2024 1.87 Bn
Jun 30, 2024 1.80 Bn
Mar 31, 2024 1.83 Bn
Dec 31, 2023 1.52 Bn
Sep 30, 2023 1.65 Bn
Jun 30, 2023 1.67 Bn
Mar 31, 2023 1.72 Bn
Dec 31, 2022 1.76 Bn
Sep 30, 2022 1.75 Bn
Jun 30, 2022 1.81 Bn
Mar 31, 2022 1.88 Bn
Dec 31, 2021 1.93 Bn
Sep 30, 2021 2.05 Bn